Brochure | January 4, 2022

Strategically Located Manufacturing Facilities

iStock-136140244-lab-pharma-equipment-process

Strategically located in three continents — Europe, Asia and America — our 4 full cGMP state-of-the-art multipurpose manufacturing sites provide a total reaction volume capacity of 875 m³ to guarantee perfect solutions for chemical and pharmaceutical intermediates or APIs.

Our pharmaceutical approach to chemical manufacturing (class 100,000 clean rooms for the last steps of synthesis) ensures full control of our products and processes according to the strictest quality standards.

A continuous investment policy keeps our manufacturing sites on a perfect compliance status by allowing us to implement new production technologies, such as Spray Drying, flow chemistry, HPAPI manufacture, etc...

Our global R&D team gathers 102 people and ensures that the knowledge on processes and new technologies is spread to all our manufacturing sites. Our global compliance management guarantees a European design, manufacturing and control in all our facilities.

VIEW THE BROCHURE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online